Back to
GOLDMAN SACHS GROUP INC
QNCX6 quarters
Position history for
GOLDMAN SACHS GROUP INC's holdings in QUINCE THERAPEUTICS INC
As of its Q1 2026 13F, Goldman Sachs held 16,064 shares of QNCX (Quince Therapeutics), worth $1,629. Goldman Sachs' 13F filings listed QNCX from Q4 2025 to Q1 2026, 2 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$196,000
Total Shares Change
-88,354
Quarter-by-Quarter History
Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors